Tag: Antibiotics

Antibiotics, also called antibacterials, are a type of antimicrobial drug used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. A limited number of antibiotics also possess antiprotozoal activity. Antibiotics are not effective against viruses such as the common cold or influenza, and their inappropriate use allows the emergence of resistant organisms. Drugs which inhibit viruses are termed antiviral drugs or antivirals rather than antibiotics.
Sometimes the term antibiotic (which means “opposing life”) is used to refer to any substance used against microbes, synonymous with antimicrobial. Some sources distinguish between antibacterial and antibiotic; antibacterials are used in soaps and disinfectants, while antibiotics are used as medicine. Antibiotics revolutionized medicine in the 20th century, and have together with vaccination led to the near eradication of diseases such as tuberculosis in the developed world. However, their effectiveness and easy access led to overuse, especially in livestock raising, prompting bacteria to develop resistance. This has led to widespread problems with antimicrobial and antibiotic resistance, so much as to prompt the World Health Organization to classify antimicrobial resistance as a “serious threat [that] is no longer a prediction for the future, it is happening right now in every region of the world and has the potential to affect anyone, of any age, in any country”. All classes of antibiotics in use today were first discovered prior to the mid 1980s.

Biokhimik launches full-cycle manufacturing of antibiotics

For the first time in a quarter of century, Russia launched the full-cycle manufacturing of antibiotics based exclusively on domestic components.

FDA published its updated Guidance on Systemic Antibacterial Drugs

The purpose of this guidance is to assist sponsors in the development, analysis, and presentation of microbiology data during antibacterial drug development.

WHO published new insights on antibiotic resistance

antimicrobial resistance
WHO’s first release of surveillance data on antibiotic resistance reveals high levels of resistance to a number of serious bacterial infections in both high- and low-income countries

The University of Geneva and AstraZeneca manage a new research project

microbiology plates
The research project DRIVE-AB has determined that a market entry reward of $1 billion per antibiotic globally could significantly increase the number of new antibiotics coming to the market in the next 30 years

Biokhimik will begin to produce more than 20 latest-generation antibiotics

manufacturing at biokhimik
The development of Biokhimik plant was discussed during the meeting between the Head of the Republic of Mordovia and the Chairman of the Board of Directors of Promomed Company

Novasep will manufacture API for Tetraphase’s novel antibiotic

antimicrobial resistance
Novasep announced that it has been selected by Tetraphase for the commercial manufacture of the active pharmaceutical ingredient eravacycline

Scientists in Kazakhstan developed a novel antifungal medicine

The first locally developed novel broad-spectrum medicine for the treatment of fungal skin diseases was created in Kazakhstan

Symcel received funding for antibiotic susceptibility testing

Symcel has secured funding to support the company’s evaluation of improved combination testing of antibiotics against extensively drug-resistant bacteria

A hemostatic agent for cardiac surgery was developed in Russia

The researchers created a drug to stop the bleeding in open surgery, , including open-heart procedures

Scientists developing a new approach to antibiotic resistance

antibiotic resistance
Researchers at the University of Maryland School of Medicine are studying how to fend off deadly infections by targeting the body's immune response to bacteria

Russian manufacturers of antibiotics strengthen their market positions

The volume of antibiotics market in Russia reached 19.7 billion rubles in prices of final consumption or 120 million packages

Warp Drive Bio and Roche will jointly develop new classes of antibiotics

Warp Drive Bio, Inc., a drug discovery company, announced today that it has formed a strategic collaboration with Roche

WHO supplied 1.2 million antibiotics for a struggle with plague in Madagascar

WHO has delivered nearly 1.2 million doses of antibiotics and released $1.5 million in emergency funds to fight plague in Madagascar

Biokhimik started production of a new generation antibiotic substance

On October 3, the specialists of Biokhimik PJSC produced the first experimental and industrial lot of antibiotic substance for Vancomycin

RF approved the Strategy on Prevention of Antimicrobial Resistance

government russia
Prime Minister Dmitry Medvedev signed an Order approving the Strategy on Prevention and Containment of Antimicrobial Resistance in the Russian Federation for the Period until 2030.

WHO released alarming report on antibiotics development

A report launched today by WHO shows a serious lack of new antibiotics under development to combat the growing threat of antimicrobial resistance